Relevant risk for interaction seen with cardiac implantable electronic devices; no signs of cardiac damage seen during testing.

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.

Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

(HealthDay News) — Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a ...

Many cancer patients prefer using telemedicine over in-person visits when completing the informed consent process, a study suggests.

Painful diabetic neuropathy was associated with lower quality of life and higher rates of depression and anxiety than painless diabetic neuropathy.

Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

A risk-standardized model that includes patient factors, such as age and cardiogenic shock, can predict in-hospital mortality in patients with AMI. A new risk-standardized model can predict in ...

(HealthDay News) — The U.S. Senate has confirmed the appointment of Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services (CMS), according to a report from The New York Times.